Header Logo

Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by BEHRANG AMINI and AMOL JITENDRA GHIA.
BEHRANG AMINI
Connection Strength
4.928
AMOL JITENDRA GHIA
  1. Osseous Pseudoprogression in Vertebral Bodies Treated with Stereotactic Radiosurgery: A Secondary Analysis of Prospective Phase I/II Clinical Trials. AJNR Am J Neuroradiol. 2016 Feb; 37(2):387-92.
    View in: PubMed
    Score: 0.530
  2. Validation of the prognostic index for spine metastasis (PRISM) for stratifying survival in patients treated with spinal stereotactic body radiation. Radiother Oncol. 2024 Dec; 201:110570.
    View in: PubMed
    Score: 0.246
  3. Stereotactic radiosurgery for prostate cancer spine metastases: local control and fracture risk using a simultaneous integrated boost approach. J Neurosurg Spine. 2024 Sep 01; 41(3):436-444.
    View in: PubMed
    Score: 0.241
  4. Management of chordoma and chondrosarcoma with definitive dose-escalated single-fraction spine stereotactic radiosurgery. J Neurooncol. 2023 Sep; 164(2):377-386.
    View in: PubMed
    Score: 0.228
  5. Safety and efficacy of salvage conventional re-irradiation following stereotactic radiosurgery for spine metastases. Radiat Oncol J. 2023 Mar; 41(1):12-22.
    View in: PubMed
    Score: 0.221
  6. Safety and Efficacy of Dose-Escalated Radiation Therapy With a Simultaneous Integrated Boost for the Treatment of Spinal Metastases. Pract Radiat Oncol. 2023 Jan-Feb; 13(1):e7-e13.
    View in: PubMed
    Score: 0.215
  7. Advances in the management of spinal metastases: what the radiologist needs to know. Br J Radiol. 2023 Jan 01; 96(1141):20220267.
    View in: PubMed
    Score: 0.213
  8. Multidisciplinary management of spinal metastases: what the radiologist needs to know. Br J Radiol. 2022 Sep 01; 95(1138):20220266.
    View in: PubMed
    Score: 0.212
  9. Low risk of radiation myelopathy with relaxed spinal cord dose constraints in de novo, single fraction spine stereotactic radiosurgery. Radiother Oncol. 2020 11; 152:49-55.
    View in: PubMed
    Score: 0.184
  10. Spine stereotactic radiosurgery for metastases from hepatobiliary malignancies: patient selection using PRISM scoring. J Neurooncol. 2020 Jun; 148(2):327-334.
    View in: PubMed
    Score: 0.181
  11. Spine stereotactic radiosurgery for metastatic thyroid cancer: a single-institution experience. J Neurosurg Spine. 2020 06 01; 32(6):941-949.
    View in: PubMed
    Score: 0.179
  12. Low incidence of late failure and toxicity after spine stereotactic radiosurgery: Secondary analysis of phase I/II trials with long-term follow-up. Radiother Oncol. 2019 09; 138:80-85.
    View in: PubMed
    Score: 0.171
  13. Outcomes After Hypofractionated Dose-Escalation using a Simultaneous Integrated Boost Technique for Treatment of Spine Metastases Not Amenable to Stereotactic Radiosurgery. Pract Radiat Oncol. 2019 Mar; 9(2):e142-e148.
    View in: PubMed
    Score: 0.163
  14. Heterogeneity in Treatment Response of Spine Metastases to Spine Stereotactic Radiosurgery Within "Radiosensitive" Subtypes. Int J Radiat Oncol Biol Phys. 2017 12 01; 99(5):1207-1215.
    View in: PubMed
    Score: 0.151
  15. Spine stereotactic radiosurgery for metastatic sarcoma: patterns of failure and radiation treatment volume considerations. J Neurosurg Spine. 2017 Sep; 27(3):303-311.
    View in: PubMed
    Score: 0.149
  16. Internal validation of the prognostic index for spine metastasis (PRISM) for stratifying survival in patients treated with spinal stereotactic radiosurgery. J Radiosurg SBRT. 2017; 5(1):25-34.
    View in: PubMed
    Score: 0.144
  17. Spine Stereotactic Radiosurgery for Patients with Metastatic Thyroid Cancer: Secondary Analysis of Phase I/II Trials. Thyroid. 2016 09; 26(9):1269-75.
    View in: PubMed
    Score: 0.140
  18. The use of spine stereotactic radiosurgery for oligometastatic disease. J Neurosurg Spine. 2016 Aug; 25(2):239-47.
    View in: PubMed
    Score: 0.137
  19. Stereotactic Body Radiation Therapy for Spinal Metastases in the Postoperative Setting: A Secondary Analysis of Mature Phase 1-2 Trials. Int J Radiat Oncol Biol Phys. 2016 08 01; 95(5):1405-1413.
    View in: PubMed
    Score: 0.136
  20. Single-fraction versus multifraction spinal stereotactic radiosurgery for spinal metastases from renal cell carcinoma: secondary analysis of Phase I/II trials. J Neurosurg Spine. 2016 May; 24(5):829-36.
    View in: PubMed
    Score: 0.135
  21. Creation of a Prognostic Index for Spine Metastasis to Stratify Survival in Patients Treated With Spinal Stereotactic Radiosurgery: Secondary Analysis of Mature Prospective Trials. Int J Radiat Oncol Biol Phys. 2015 Sep 01; 93(1):118-25.
    View in: PubMed
    Score: 0.128
  22. Outcomes for Spine Stereotactic Body Radiation Therapy and an Analysis of Predictors of Local Recurrence. Int J Radiat Oncol Biol Phys. 2015 Aug 01; 92(5):1016-1026.
    View in: PubMed
    Score: 0.127
  23. Incidence and predictive factors of pain flare after spine stereotactic body radiation therapy: secondary analysis of phase 1/2 trials. Int J Radiat Oncol Biol Phys. 2014 Nov 15; 90(4):870-6.
    View in: PubMed
    Score: 0.123
  24. Spinal laser interstitial thermal therapy and radiotherapy for thoracic metastatic epidural spinal cord compression. J Neurooncol. 2024 Nov; 170(2):289-296.
    View in: PubMed
    Score: 0.061
  25. Definitive single fraction spine stereotactic radiosurgery for metastatic sarcoma: Simultaneous integrated boost is associated with high tumor control and low vertebral fracture risk. Radiother Oncol. 2024 04; 193:110119.
    View in: PubMed
    Score: 0.059
  26. Quantification of MRI Artifacts in Carbon Fiber Reinforced Polyetheretherketone Thoracolumbar Pedicle Screw Constructs prior to Spinal Stereotactic Radiosurgery. Pract Radiat Oncol. 2024 Mar-Apr; 14(2):103-111.
    View in: PubMed
    Score: 0.058
  27. Immune Checkpoint Inhibitors Have Clinical Activity in Patients With Recurrent Chordoma. J Immunother. 2022 10 01; 45(8):374-378.
    View in: PubMed
    Score: 0.053
  28. Spinal laser interstitial thermal therapy: single-center experience and outcomes in the first 120 cases. J Neurosurg Spine. 2021 03 01; 34(3):354-363.
    View in: PubMed
    Score: 0.047
  29. A comparison of spinal laser interstitial thermotherapy with open surgery for metastatic thoracic epidural spinal cord compression. J Neurosurg Spine. 2020 05 01; 32(5):667-675.
    View in: PubMed
    Score: 0.044
  30. Spine Stereotactic Radiosurgery for Metastatic Pheochromocytoma. Cureus. 2019 May 23; 11(5):e4742.
    View in: PubMed
    Score: 0.042
  31. A Novel Use of the Intraoperative MRI for Metastatic Spine Tumors: Laser Interstitial Thermal Therapy for Percutaneous Treatment of Epidural Metastatic Spine Disease. Neurosurg Clin N Am. 2017 Oct; 28(4):513-524.
    View in: PubMed
    Score: 0.038
  32. Image guidance based on MRI for spinal interstitial laser thermotherapy: technical aspects and accuracy. J Neurosurg Spine. 2017 May; 26(5):605-612.
    View in: PubMed
    Score: 0.036
  33. Spinal Laser Interstitial Thermal Therapy: A Novel Alternative to Surgery for Metastatic Epidural Spinal Cord Compression. Neurosurgery. 2016 Dec; 79 Suppl 1:S73-S82.
    View in: PubMed
    Score: 0.036
  34. Percutaneous surgery for treatment of epidural spinal cord compression and spinal instability: technical note. Neurosurg Focus. 2016 Oct; 41(4):E2.
    View in: PubMed
    Score: 0.035
  35. Can the spinal instability neoplastic score prior to spinal radiosurgery predict compression fractures following stereotactic spinal radiosurgery for metastatic spinal tumor?: a post hoc analysis of prospective phase II single-institution trials. J Neurooncol. 2016 Feb; 126(3):509-17.
    View in: PubMed
    Score: 0.033
  36. Utilization of laser interstitial thermotherapy guided by real-time thermal MRI as an alternative to separation surgery in the management of spinal metastasis. J Neurosurg Spine. 2015 Oct; 23(4):400-11.
    View in: PubMed
    Score: 0.032
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.